News

Hosted on MSN1mon
MEREO BIOPHARMA (MREO) Upgraded to Buy: What Does It Mean for the Stock?
Mereo BioPharma Group plc - Sponsored ADR (MREO) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in ...
Yahoo Finance10d
Mereo BioPharma Group plc (MREO)
A live audio webcast of the presentation can be accessed through the Investors section of the Company’s website at www.mereo LONDON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc ...
Hosted on MSN1mon
JP Morgan Initiates Coverage of Mereo BioPharma Group plc - Depositary Receipt () (MREO) with Overweight Recommendation
Analyst Price Forecast Suggests 218.48% Upside As of March 19, 2025, the average one-year price target for Mereo BioPharma Group plc - Depositary Receipt is $7.48/share. The forecasts range from a ...
pharmaphorum5y
UK biotech Mereo gears up for key brittle bone drug data
UK biotech Mereo BioPharma is hoping the coming months will transform its fortunes as it prepares for potentially pivotal data for a brittle bone disease drug. Mereo is developing setrusumab for ...
Hosted on MSN1mon
Mereo wins New Overweight at J.P. Morgan ahead of trial readouts
Mereo BioPharma (NASDAQ:MREO) traded higher on Thursday after J.P. Morgan launched its coverage with an overweight recommendation, citing two late-stage trial readouts the U.K.-based biotech is ...